Nihar Desai/X
Nov 7, 2024, 14:58
Nihar Desai: Daratumumab in the Management of Red Cell Aplasia
Nihar Desai, Co-Founder, HaemBytes, posted on X about recent paper by him as first author, titled “Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell Transplantation” published on European Journal of Hematology.
Authors: Nihar Desai, Auro Viswabandya, Dennis Dong Hwan Kim, Jeffrey H. Lipton, Jonas Mattsson, Arjun Datt Law
“New publication from our group, out in European Journal of Hematology
Red cell aplasia is uncommon but causes significant morbidity
Daratumumab is effective, well tolerated, and leads to rapid and sustained responses
DM me for the PDF.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 7, 2024, 14:58
Nov 7, 2024, 14:53
Nov 7, 2024, 14:40
Nov 7, 2024, 13:51
Nov 7, 2024, 13:12
Nov 7, 2024, 13:07
Nov 7, 2024, 12:50
Nov 7, 2024, 12:49
Nov 7, 2024, 12:27
Nov 7, 2024, 12:19